Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.31 |
| ▸ | CCR5 | P51681 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21531398 | 1.00 | MEN1 (0.35) | MEN1KMT2ACA12AKR1B10CA1 | |
| SCHEMBL15364319 | 0.79 | CA12 (0.42) | MEN1KMT2ACA12CA1CA2 | |
| SCHEMBL23653647 | 0.75 | CA12 (0.46) | CA12CA1CA2CA7CA9 | |
| SCHEMBL22779641 | 0.70 | CCNC (0.31) | — | |
| Alanine SCHEMBL10400294 | 0.69 | — | — | |
| SCHEMBL7804572 | 0.69 | AKR1B10 (0.54) | MEN1KMT2ACA12AKR1B10CA1 | |
| SCHEMBL22881950 | 0.68 | APP (0.34) | AKR1B10AKR1B1HCAR2KDM4EALDH1A1 | |
| SCHEMBL16844231 | 0.67 | HDAC1 (0.33) | — | |
| SCHEMBL9303334 | 0.67 | CYP1A2 (0.39) | KMT2ATDP1KDM4EALDH1A1HPGD | |
| SCHEMBL18648890 | 0.66 | CYP2C9 (0.59) | MEN1KMT2ATDP1HCAR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11219230-B2 | Mixtures with stabilising properties | SYMRISE AG (DE) | 2022-01-11 | — | — | US | disclosed |
| US-20190336423-A1 | MIXTURES WITH STABILISING PROPERTIES | SYMRISE AG (DE) | 2019-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11219230-B2 | Mixtures with stabilising properties | LPO, TAS2R50, TAS2R10 | MEN1 2346/4885KMT2A 4117/4885CA12 1655/4885 |
| US-20190336423-A1 | MIXTURES WITH STABILISING PROPERTIES | LPO, TAS2R50, TAS2R10 | MEN1 2346/4885KMT2A 4117/4885CA12 1655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.